John A. Glaspy, MD, MPH
Simms/Mann Family Foundation Endowed Chair in Integrative Oncology at UCLA
John Glaspy, MD, MPH holds the Simms/Mann Family Foundation Endowed Chair in Integrative Oncology at UCLA and is the Medical Director of the Simms/Mann-UCLA Center for Integrative Oncology. Dr. Glaspy is professor of medicine in the Department of Medicine, Division of Hematology/Oncology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Dr. Glaspy serves as co-chair to the division with Dr. Dennis Slamon. He is director of the JCCC Clinical Research Unit and director of the JCCC Women’s Cancer Research Program. He is a researcher and oncologist with a national reputation in clinical medicine as an acute diagnostician and outstanding clinician.
Dr. Glaspy is professor of medicine in the Department of Medicine, Division of Hematology/Oncology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Dr. Glaspy serves as co-chair to the division with Dr. Dennis Slamon. He is director of the JCCC Clinical Research Unit and director of the JCCC Women’s Cancer Research Program. He is a researcher and oncologist with a national reputation in clinical medicine as an acute diagnostician and outstanding clinician.
Dr. Glaspy is a member of the American Society of Clinical Oncology, Southwest Oncology Group, American Federation for Clinical Research, International Society of Interferon Research, and American Society of Nuclear Medicine, among others. He is also a fellow of the American College of Physicians. During the course of his career, Dr. Glaspy has authored more than 270 articles, abstracts, and book chapters. He has received numerous awards and honors, including being named one of the “Best Doctors in America.”
Currently, Dr. Glaspy is involved in basic research in tumor immunology and the effects of fatty acids on carcinogenesis. His clinical interests also include chemotherapy-induced anemia, the role of hematopoietic growth factors in cancer management, and new approaches to the treatment of breast cancer and malignant melanoma. Dr. Glaspy received his MD from the UCLA School of Medicine and his MPH in health services administration from the UCLA School of Public Health. He completed his residency in internal medicine and his fellowship in hematology and oncology at the UCLA School of Medicine.
Dr. Glaspy understands the value of providing integrative care to patients with cancer and has been a strong advocate for these services. He is devoted to providing the leadership from the Department of Medicine on the Founders Board because of his strong belief in the mission of the Simms/Mann Center. He considers the Simms/Mann Center to be an essential part of comprehensive oncology care.
https://www.simmsmanncenter.ucla.edu/
Margo B. Minissian, PhD, ACNP
Simms/Mann Family Foundation Endowed Chair in Nurse Education, Innovation, and Research at Cedars-Sinai
Margo B. Minissian, PhD, ACNP is the Margo B. Minissian, PhD, ACNP is the Simms/Mann Family Foundation Endowed Chair in Nurse Education, Innovation, and Research at Cedars-Sinai. Dr. Minissian is the Executive Director of the Brawerman Nursing Institute and oversees education, research and performance improvement. She is Assistant Professor of Cardiology at Cedars-Sinai Medical Center. She completed a biological research PhD at the UCLA School of Nursing, was the UCLA Dean’s Scholar Fellow and Regents Scholar. Her research focuses on cardiovascular prevention with an emphasis on young women who experience severe preterm delivery and preeclampsia. Her work has earned numerous awards and funding from the National of Institutes of Health.
As a researcher who examines ways to prevent disease, Minissian has a strong interest in protecting healthcare workers during the ongoing Covid-19 pandemic. Her team of co-investigators enrolled registered nurses in a study that seeks to measure and quantify inflammatory proteins which signal prior to a healthy person becoming sick. “By evaluating these proteins immediately before shift work, we might be able to reduce the risk nurses face when caring for COVID-19 patients”. Minissian adds, “The ultimate goal is to develop a point of care screening test to help healthcare workers stay healthy while caring for our critically ill on the front-lines”.
http://www.cedars-sinai.org/newsroom/simmsmann-family-foundation-establishes-chair-at-cedars-sinai/